Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1996 Apr;64(4):1100–1109. doi: 10.1128/iai.64.4.1100-1109.1996

Induction of common mucosal immunity by hormonally immunomodulated peripheral immunization.

R A Daynes 1, E Y Enioutina 1, S Butler 1, H H Mu 1, Z A McGee 1, A Araneo B 1
PMCID: PMC173890  PMID: 8606065

Abstract

The study described in this report demonstrates that peripheral lymph nodes draining nonmucosal tissues can effectively serve as induction sites for the establishment of common mucosal immunity if the microenvironmental conditions are altered to mimic those normally present within mucosa-associated lymphoid tissues (e.g., Peyer's patches). Lymph node lymphocytes exposed in situ to the immunomodulatory influences of the hormone 1 alpha, 25-dihydroxy vitamin D 3 were found to produce less gamma interferon and interleukin-2 (IL-2) and far more IL-4, IL-5 and IL-10 than lymphocytes from control animals. When couples with vaccination with hepatitis B surface antigen (HBsAg), the hormone, immunomodulated switch from a peripheral lymph node phenotype to a Peyer's patch-like pattern promoted the induction of both a systemic and a common mucosal immune response. This was determined by the observed increased concentrations of serum anti-HBsAg antibody and by finding that anti-HBsAg secretory antibodies were detectable in urogenital, lachrymal, fecal and oral secretions only in the hormone-treated animals. In addition, specific antibody-secreting cells were detectable in the lamina propria of the lungs and small intestines of the hormone-treated animals subsequent to vaccination, indicating that the homing properties of antigen-specific B cells were being affected by the treatment procedure. The humoral and mucosal immune responses were further augmented if both 1 alpha, 25-dihydroxy vitamin D 3 and dehydroepiandrosterone were used together as hormonal immunomodulators. This novel immunization technique may afford new opportunities to effectively intervene in sexually transmitted diseases and other diseases caused by mucosal pathogens.

Full Text

The Full Text of this article is available as a PDF (324.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abraham E., Shah S. Intranasal immunization with liposomes containing IL-2 enhances bacterial polysaccharide antigen-specific pulmonary secretory antibody response. J Immunol. 1992 Dec 1;149(11):3719–3726. [PubMed] [Google Scholar]
  2. Alter M. J., Ahtone J., Weisfuse I., Starko K., Vacalis T. D., Maynard J. E. Hepatitis B virus transmission between heterosexuals. JAMA. 1986 Sep 12;256(10):1307–1310. [PubMed] [Google Scholar]
  3. Araneo B. A., Dowell T., Diegel M., Daynes R. A. Dihydrotestosterone exerts a depressive influence on the production of interleukin-4 (IL-4), IL-5, and gamma-interferon, but not IL-2 by activated murine T cells. Blood. 1991 Aug 1;78(3):688–699. [PubMed] [Google Scholar]
  4. Araneo B. A., Woods M. L., 2nd, Daynes R. A. Reversal of the immunosenescent phenotype by dehydroepiandrosterone: hormone treatment provides an adjuvant effect on the immunization of aged mice with recombinant hepatitis B surface antigen. J Infect Dis. 1993 Apr;167(4):830–840. doi: 10.1093/infdis/167.4.830. [DOI] [PubMed] [Google Scholar]
  5. Archibald D. W., Hebert C. A., Sun D., Tacket C. O. Salivary antibodies to human immunodeficiency virus type 1 in a phase I AIDS vaccine trial. J Acquir Immune Defic Syndr. 1990;3(10):954–958. [PubMed] [Google Scholar]
  6. Beagley K. W., Eldridge J. H., Kiyono H., Everson M. P., Koopman W. J., Honjo T., McGhee J. R. Recombinant murine IL-5 induces high rate IgA synthesis in cycling IgA-positive Peyer's patch B cells. J Immunol. 1988 Sep 15;141(6):2035–2042. [PubMed] [Google Scholar]
  7. Beagley K. W., Elson C. O. Cells and cytokines in mucosal immunity and inflammation. Gastroenterol Clin North Am. 1992 Jun;21(2):347–366. [PubMed] [Google Scholar]
  8. Beasley R. P., Hwang L. Y., Lin C. C., Chien C. S. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 1981 Nov 21;2(8256):1129–1133. doi: 10.1016/s0140-6736(81)90585-7. [DOI] [PubMed] [Google Scholar]
  9. Bhalla A. K., Amento E. P., Krane S. M. Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production. Cell Immunol. 1986 Apr 1;98(2):311–322. doi: 10.1016/0008-8749(86)90291-1. [DOI] [PubMed] [Google Scholar]
  10. Cao W. W., Wang R. F., Slavik M. Development of a simplified method for subclass isotyping and screening monoclonal antibodies. Biotechniques. 1991 May;10(5):574–578. [PubMed] [Google Scholar]
  11. Davies M. D., Parrott D. M. Preparation and purification of lymphocytes from the epithelium and lamina propria of murine small intestine. Gut. 1981 Jun;22(6):481–488. doi: 10.1136/gut.22.6.481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Daynes R. A., Araneo B. A., Dowell T. A., Huang K., Dudley D. Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function. J Exp Med. 1990 Apr 1;171(4):979–996. doi: 10.1084/jem.171.4.979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Daynes R. A., Araneo B. A. The development of effective vaccine adjuvants employing natural regulators of T-cell lymphokine production in vivo. Ann N Y Acad Sci. 1994 Aug 15;730:144–161. doi: 10.1111/j.1749-6632.1994.tb44246.x. [DOI] [PubMed] [Google Scholar]
  14. Daynes R. A., Dowell T., Araneo B. A. Platelet-derived growth factor is a potent biologic response modifier of T cells. J Exp Med. 1991 Dec 1;174(6):1323–1333. doi: 10.1084/jem.174.6.1323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Daynes R. A., Dudley D. J., Araneo B. A. Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells. Eur J Immunol. 1990 Apr;20(4):793–802. doi: 10.1002/eji.1830200413. [DOI] [PubMed] [Google Scholar]
  16. Defrance T., Vanbervliet B., Brière F., Durand I., Rousset F., Banchereau J. Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J Exp Med. 1992 Mar 1;175(3):671–682. doi: 10.1084/jem.175.3.671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Finkelman F. D., Holmes J., Katona I. M., Urban J. F., Jr, Beckmann M. P., Park L. S., Schooley K. A., Coffman R. L., Mosmann T. R., Paul W. E. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol. 1990;8:303–333. doi: 10.1146/annurev.iy.08.040190.001511. [DOI] [PubMed] [Google Scholar]
  18. Hajishengallis G., Hollingshead S. K., Koga T., Russell M. W. Mucosal immunization with a bacterial protein antigen genetically coupled to cholera toxin A2/B subunits. J Immunol. 1995 May 1;154(9):4322–4332. [PubMed] [Google Scholar]
  19. Harriman G. R., Kunimoto D. Y., Elliott J. F., Paetkau V., Strober W. The role of IL-5 in IgA B cell differentiation. J Immunol. 1988 May 1;140(9):3033–3039. [PubMed] [Google Scholar]
  20. Holmgren J., Lycke N., Czerkinsky C. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine. 1993 Sep;11(12):1179–1184. doi: 10.1016/0264-410x(93)90039-z. [DOI] [PubMed] [Google Scholar]
  21. Hou M. C., Wu J. C., Kuo B. I., Sheng W. Y., Chen T. Z., Lee S. D., Lo K. J. Heterosexual transmission as the most common route of acute hepatitis B virus infection among adults in Taiwan--the importance of extending vaccination to susceptible adults. J Infect Dis. 1993 Apr;167(4):938–941. doi: 10.1093/infdis/167.4.938. [DOI] [PubMed] [Google Scholar]
  22. Husband A. J. Novel vaccination strategies for the control of mucosal infection. Vaccine. 1993;11(2):107–112. doi: 10.1016/0264-410x(93)90003-g. [DOI] [PubMed] [Google Scholar]
  23. Kilshaw P. J., Murant S. J. A new surface antigen on intraepithelial lymphocytes in the intestine. Eur J Immunol. 1990 Oct;20(10):2201–2207. doi: 10.1002/eji.1830201008. [DOI] [PubMed] [Google Scholar]
  24. Kiyono H., Bienenstock J., McGhee J. R., Ernst P. B. The mucosal immune system: features of inductive and effector sites to consider in mucosal immunization and vaccine development. Reg Immunol. 1992 Mar-Apr;4(2):54–62. [PubMed] [Google Scholar]
  25. Lebman D. A., Lee F. D., Coffman R. L. Mechanism for transforming growth factor beta and IL-2 enhancement of IgA expression in lipopolysaccharide-stimulated B cell cultures. J Immunol. 1990 Feb 1;144(3):952–959. [PubMed] [Google Scholar]
  26. Lebman D. A., Nomura D. Y., Coffman R. L., Lee F. D. Molecular characterization of germ-line immunoglobulin A transcripts produced during transforming growth factor type beta-induced isotype switching. Proc Natl Acad Sci U S A. 1990 May;87(10):3962–3966. doi: 10.1073/pnas.87.10.3962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Lemire J. M., Archer D. C. 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest. 1991 Mar;87(3):1103–1107. doi: 10.1172/JCI115072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Lemire J. M., Archer D. C., Reddy G. S. 1,25-Dihydroxy-24-OXO-16ene-vitamin D3, a renal metabolite of the vitamin D analog 1,25-dihydroxy-16ene-vitamin D3, exerts immunosuppressive activity equal to its parent without causing hypercalcemia in vivo. Endocrinology. 1994 Dec;135(6):2818–2821. doi: 10.1210/endo.135.6.7988477. [DOI] [PubMed] [Google Scholar]
  29. Lemire J. M. Immunomodulatory role of 1,25-dihydroxyvitamin D3. J Cell Biochem. 1992 May;49(1):26–31. doi: 10.1002/jcb.240490106. [DOI] [PubMed] [Google Scholar]
  30. Mazanec M. B., Kaetzel C. S., Lamm M. E., Fletcher D., Nedrud J. G. Intracellular neutralization of virus by immunoglobulin A antibodies. Proc Natl Acad Sci U S A. 1992 Aug 1;89(15):6901–6905. doi: 10.1073/pnas.89.15.6901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. McGhee J. R., Mestecky J., Dertzbaugh M. T., Eldridge J. H., Hirasawa M., Kiyono H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine. 1992;10(2):75–88. doi: 10.1016/0264-410x(92)90021-b. [DOI] [PubMed] [Google Scholar]
  32. Mestecky J. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol. 1987 Jul;7(4):265–276. doi: 10.1007/BF00915547. [DOI] [PubMed] [Google Scholar]
  33. Minghetti P. P., Norman A. W. 1,25(OH)2-vitamin D3 receptors: gene regulation and genetic circuitry. FASEB J. 1988 Dec;2(15):3043–3053. doi: 10.1096/fasebj.2.15.2847948. [DOI] [PubMed] [Google Scholar]
  34. Mosmann T. R., Coffman R. L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989;7:145–173. doi: 10.1146/annurev.iy.07.040189.001045. [DOI] [PubMed] [Google Scholar]
  35. Murray P. D., McKenzie D. T., Swain S. L., Kagnoff M. F. Interleukin 5 and interleukin 4 produced by Peyer's patch T cells selectively enhance immunoglobulin A expression. J Immunol. 1987 Oct 15;139(8):2669–2674. [PubMed] [Google Scholar]
  36. Nedrud J. G., Liang X. P., Hague N., Lamm M. E. Combined oral/nasal immunization protects mice from Sendai virus infection. J Immunol. 1987 Nov 15;139(10):3484–3492. [PubMed] [Google Scholar]
  37. Petkovich P. M., Wrana J. L., Grigoriadis A. E., Heersche J. N., Sodek J. 1,25-Dihydroxyvitamin D3 increases epidermal growth factor receptors and transforming growth factor beta-like activity in a bone-derived cell line. J Biol Chem. 1987 Oct 5;262(28):13424–13428. [PubMed] [Google Scholar]
  38. Reichel H., Koeffler H. P., Tobler A., Norman A. W. 1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sci U S A. 1987 May;84(10):3385–3389. doi: 10.1073/pnas.84.10.3385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Roberts M., Cropley I., Chatfield S., Dougan G. Protection of mice against respiratory Bordetella pertussis infection by intranasal immunization with P.69 and FHA. Vaccine. 1993;11(8):866–872. doi: 10.1016/0264-410x(93)90363-3. [DOI] [PubMed] [Google Scholar]
  40. Romagnani S. Induction of TH1 and TH2 responses: a key role for the 'natural' immune response? Immunol Today. 1992 Oct;13(10):379–381. doi: 10.1016/0167-5699(92)90083-J. [DOI] [PubMed] [Google Scholar]
  41. Rosenblum L. S., Hadler S. C., Castro K. G., Lieb S., Jaffe H. W. Heterosexual transmission of hepatitis B virus in Belle Glade, Florida. Belle Glade Study Group. J Infect Dis. 1990 Mar;161(3):407–411. doi: 10.1093/infdis/161.3.407. [DOI] [PubMed] [Google Scholar]
  42. Schieferdecker H. L., Ullrich R., Weiss-Breckwoldt A. N., Schwarting R., Stein H., Riecken E. O., Zeitz M. The HML-1 antigen of intestinal lymphocytes is an activation antigen. J Immunol. 1990 Apr 1;144(7):2541–2549. [PubMed] [Google Scholar]
  43. Schumacher J. H., O'Garra A., Shrader B., van Kimmenade A., Bond M. W., Mosmann T. R., Coffman R. L. The characterization of four monoclonal antibodies specific for mouse IL-5 and development of mouse and human IL-5 enzyme-linked immunosorbent. J Immunol. 1988 Sep 1;141(5):1576–1581. [PubMed] [Google Scholar]
  44. Sedgwick J. D., Holt P. G. The ELISA-plaque assay for the detection and enumeration of antibody-secreting cells. An overview. J Immunol Methods. 1986 Feb 27;87(1):37–44. doi: 10.1016/0022-1759(86)90341-8. [DOI] [PubMed] [Google Scholar]
  45. West D. J. Clinical experience with hepatitis B vaccines. Am J Infect Control. 1989 Jun;17(3):172–180. doi: 10.1016/0196-6553(89)90213-7. [DOI] [PubMed] [Google Scholar]
  46. Wilson A. D., Bailey M., Williams N. A., Stokes C. R. The in vitro production of cytokines by mucosal lymphocytes immunized by oral administration of keyhole limpet hemocyanin using cholera toxin as an adjuvant. Eur J Immunol. 1991 Oct;21(10):2333–2339. doi: 10.1002/eji.1830211007. [DOI] [PubMed] [Google Scholar]
  47. Wu H. Y., Russell M. W. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect Immun. 1993 Jan;61(1):314–322. doi: 10.1128/iai.61.1.314-322.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. deVos T., Dick T. A. A rapid method to determine the isotype and specificity of coproantibodies in mice infected with Trichinella or fed cholera toxin. J Immunol Methods. 1991 Aug 9;141(2):285–288. doi: 10.1016/0022-1759(91)90155-9. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES